MoneyWorks4Me

Ind-Swift Laboratories informs about disclosures

22 Apr 2026 Evaluate

Ind-Swift Laboratories has informed that it enclosed disclosures received under Regulation 29(2) of SEBI (Substantial acquisition of Shares and Takeover) Regulations, 2011 received by the Company on 21st April, 2026 from HCP Investments.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..